Stay updated on Immunotherapy for Anal Canal Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy for Anal Canal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record’s submission and posting dates advanced from November 11–13 to November 17–18, 2026, and the site revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T14:03:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record’s update dates changed from September 2026 to November 2026, reflecting a more recent submission and posting.
    Difference
    0.1%
    Check dated 2026-11-14T14:02:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The record now presents details for a phase II study of nivolumab with or without ipilimumab for refractory metastatic anal canal cancer, including eligibility, treatment arms, outcomes, and study locations. It also includes posted results and study documents.
    Difference
    100%
    Check dated 2026-11-07T13:40:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.8.0 instead of v3.7.2, while the study page remains an error page.
    Difference
    0.2%
    Check dated 2026-10-31T14:13:42.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The study page itself continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-24T18:43:40.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T18:19:22.000Z thumbnail image

Stay in the know with updates to Immunotherapy for Anal Canal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.